These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 30697904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MELD Exceptions and Rates of Waiting List Outcomes.
    Massie AB, Caffo B, Gentry SE, Hall EC, Axelrod DA, Lentine KL, Schnitzler MA, Gheorghian A, Salvalaggio PR, Segev DL.
    Am J Transplant; 2011 Nov; 11(11):2362-71. PubMed ID: 21920019
    [Abstract] [Full Text] [Related]

  • 8. Current Status of Simultaneous Liver-Kidney Transplantation in the United States.
    Lum EL, Cárdenas A, Martin P, Bunnapradist S.
    Liver Transpl; 2019 May; 25(5):797-806. PubMed ID: 30861294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M.
    Clin Transpl; 2012 May; ():41-65. PubMed ID: 23721009
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 13. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M, Lai Q, Sessa M, Ghinolfi D, Fallani G, Patrono D, Di Sandro S, Avolio A, Odaldi F, Bronzoni J, Tandoi F, De Carlis R, Pascale MM, Mennini G, Germinario G, Rossi M, Agnes S, De Carlis L, Cescon M, Romagnoli R, De Simone P.
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
    Umgelter A, Hapfelmeier A, Kopp W, van Rosmalen M, Rogiers X, Guba M, Eurotransplant Liver Advisory Committee.
    Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
    Wey A, Noreen S, Gentry S, Cafarella M, Trotter J, Salkowski N, Segev D, Israni A, Kasiske B, Hirose R, Snyder J.
    Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.